Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Knee Osteoarthritis
Interventions
DRUG

SAR113945

"Pharmaceutical form:Injection~Route of administration: Intra-articular"

DRUG

placebo

"Pharmaceutical form:Injection~Route of administration: Intra-articular"

Trial Locations (1)

14050

Investigational Site Number 276001, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY